SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.85-4.5%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jayhawk969 who wrote (8677)6/16/2003 9:42:02 PM
From: Biomaven  Read Replies (3) of 52153
 
Thanks, JD.

One really needs a fund that invests in these. My guess is that spreads are real bad for small trades in a lot of these preferreds. Seems like a fund investing in borderline investment grade preferreds might manage a yield of something like 6.5% (just guessing here).

Interesting to compare with muni bonds - I live in a high tax state (MA), so state taxation factors in here as well.

I read somewhere that money market funds are in trouble because their expenses are in danger of exceeding their spread (the difference between what they can earn on money and what they pay investors). An interesting thought is what happens if short term rates drop further - do the money market funds operate at a loss? go out of business? Anybody know what has happened in Japan to such funds?

An interesting thought experiment is to put you in Japan say five years ago and let you invest (locally) in any asset class you chose. I'm not sure there is anything that would have done very well for you (including the dollar). If that is the case it would be a sobering thought - sometimes there just may not be good choices.

(Of course I'm being kind of contrary by saying this on a day when the market and the biotechs were up nicely).

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext